ARCHIVES

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

July 30, 2010

NTP Board Approves Six New Projects, Tables One Other

January 23, 1981

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

Hairy Cell Leukemia Patients Have CRs In Phase I Trial

September 28, 2001

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

A Texas Radiation Center’s Survival Move Draws M.D. Anderson Into PPM Competition

February 27, 1998